FASN and cancer: We found that HepG2 and SkBr3 cells were more sensitive to C75, a chemical inhibitor of FASN, when cultured under hypoxia (Supplementary Fig. 5c), consistent with previous report that cancer cells were dependent on de novo lipid synthesis under hypoxia9.